https://www.selleckchem.com/pr....oducts/salinosporami
05). In advanced NSCLC patients who underwent second-line treatment with nivolumab, in comparison to PFS, there was a stronger correlation between PPS and OS. Our findings suggest that subsequent treatment for disease progression after a second-line nivolumab treatment had a significant impact on OS. Our findings suggest that subsequent treatment for disease progression after a second-line nivolumab treatment had a significant impact on OS.Sulfonolipids (SLs) are bacterial lipids that are structurally relate
Aimer
Commentaire
Partagez
